论文部分内容阅读
奈维拉品抗ＨＩＶ逆转录酶抑制剂奈维拉品（Ｎｅｖｉ－ｒａｐｉｎｅ）由德国贝林格尔·因格海姆公司研制。业已证明，其对红细胞系的祖代细胞的抑制作用比齐多夫定（Ｚｉｄｏｖｕｄｉｎｅ）和艾迪（ＤＤＩ）的弱·在一项与造血生长因素的结合研究结果表明，用上述三种药物...
Nevirapin anti-HIV reverse transcriptase inhibitor Nevi-rapine (Nevi-rapine) by the German company Bellinginger Ingem developed. Its inhibitory effect on progenitor cells of erythroid cells has been shown to be weaker than that of Zidovudine and Eddie (DDI) in a combination with a hematopoietic growth factor. Studies have shown that the above three drugs are used. ..